Clinical Study of Oncolytic Virus in Glioblastoma

Clinical trial NCT07145047 · RECRUITING

Trial details

NCT number: NCT07145047
Sponsor: Mianyang Central Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Glioblastoma (GBM)

Start date: 2023-11-02
Primary completion: 2025-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.